Associations between reduced diffusing capacity and airflow obstruction in community-based subjects

Respiratory Medicine

Volumn 101, Issue 8, 2007, Pages 1730-1737

  Matheson, Melanie C ^a   Raven, Joan ^b   Johns, David P ^c   Abramson, Michael J ^a   Walters, E Haydn ^c  

^a MONASH UNIVERSITY   (Australia)

^b Department of Allergy Immunology and Respiratory Medicine ^*  (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Airflow obstruction; BHR; COPD; Diffusing capacity (DLco); Epidemiology

Indexed keywords

BRONCHODILATING AGENT; CARBON MONOXIDE; METHACHOLINE; STEROID;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ATOPY; BREATH ANALYSIS; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; RISK FACTOR; RISK REDUCTION; SPIROMETRY;

AGED; AIRWAY OBSTRUCTION; BRONCHIAL HYPERREACTIVITY; COUGH; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; VICTORIA;

EID: 34250675359     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.02.020     Document Type: Article

References (45)

1. Voelkel N.F. Raising awareness of COPD in primary care. Chest 117 (2000) 372S-375S
2. World Health Organization NH, Lung and Blood Institute. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Report no. 2001. 〈www.goldcopd.com〉.
3. British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 52 (1997) S1-S28
4. Siafakas N.M., Vermeire P., Pride N.B., et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 8 (1995) 1398-1420
5. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152 (1995) S77-S121
6. McKenzie D.K., Frith P.A., Burdon J.G., et al. The COPDX Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. Med J Australia 178 (2003) S7-S39
7. Thurlbeck W.M., and Muller N.L. Emphysema: definition, imaging, and quantification. Am J Roentgenol 163 (1994) 1017-1025
8. Boschetto P., Miniati M., Miotto D., et al. Predominant emphysema phenotype in chronic obstructive pulmonary. Eur Respir J 21 (2003) 450-454
9. Park S.S., Janis M., Shim C.S., et al. Relationship of bronchitis and emphysema to altered pulmonary function. Am Rev Respir Dis 102 (1970) 927-936
10. Baldi S., Miniati M., Bellina C.R., et al. Relationship between extent of pulmonary emphysema by high-resolution computed tomography and lung elastic recoil in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 585-589
11. Make B., Miller A., Epler G., et al. Single breath diffusing capacity in the industrial setting. Chest 82 (1982) 351-356
12. Clark K.D., Wardrobe-Wong N., Elliott J.J., et al. Patterns of lung disease in a "normal" smoking population: are emphysema and airflow obstruction found together?. Chest 120 (2001) 743-747
13. Petty T.L., Silvers G.W., and Stanford R.E. Mild emphysema is associated with reduced elastic recoil and increased lung size but not with air-flow limitation. Am Rev Respir Dis 136 (1987) 867-871
14. Klein J.S., Gamsu G., Webb W.R., et al. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology 182 (1992) 817-821
15. Celli B.R., Halbert R.J., Isonaka S., et al. Population impact of different definitions of airway obstruction. Eur Respir J 22 (2003) 268-273
16. Matheson M.C., Benke G., Raven J., et al. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax 60 (2005) 645-651
17. American-Thoracic-Society. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med 152 (1996) 1107-1136
18. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update. Am J Respir Crit Care Med 152 (1995) 2185-2198
19. Gore C.J., Crockett A.J., Pederson D.G., et al. Spirometric standards for healthy adult lifetime nonsmokers in Australia. Eur Respir J 8 (1995) 773-782
20. Quanjer P.H., Dalhuijsen A., and van Zomeren B.C. Summary equations of reference values. Bull Eur Physiopathol Respir 19 (1983) 45-51
21. Quanjer P., Tammeling G.J., Cotes J.E., et al. Lung volumes and forced ventilatory flows: report of working party. Standardisation of lung function tests. European Community for Steel and Coal. Eur Respir J 6 (1993) 4-5
22. Beck K.C., Offord K.P., and Scanlon P.D. Comparison of four methods for calculating diffusing capacity by the single breath method. Chest 105 (1994) 594-600
23. O'Connor G., Sparrow D., Taylor D., et al. Analysis of dose-response curves to methacholine. An approach suitable for population studies. Am Rev of Respiratory Dis. 136 (1987) 1412-1417
24. Abramson M.J., Saunders N.A., and Hensley M.J. Analysis of bronchial reactivity in epidemiological studies. Thorax 45 (1990) 924-929
25. Fletcher C.M., Peto R., Tinker C., et al. The natural history of chronic bronchitis and emphysema: an eight year study of early chronic obstructive lung disease in working men in London (1976), Oxford University Press, Oxford
26. Doll R., Peto R., Wheatley K., et al. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309 (1994) 901-911
27. Neas L.M., and Schwartz J. The determinants of pulmonary diffusing capacity in a national sample of US adults. Am J Respir Crit Care Med 153 (1996) 656-664
28. Knudson R.J., Kaltenborn W.T., and Burrows B. The effects of cigarette smoking and smoking cessation on the carbon monoxide diffusing capacity of the lung in asymptomatic subjects. Am Rev Respir Dis 140 (1989) 645-651
29. Watson A., Joyce H., Hopper L., et al. Influence of smoking habits on change in carbon monoxide transfer factor over 10 years in middle aged men. Thorax 48 (1993) 119-124
30. Sherrill D.L., Enright P.L., Kaltenborn W.T., et al. Predictors of longitudinal change in diffusing capacity over 8 years. Am J Respir Crit Care Med 160 (1999) 1883-1887
31. Yan K., Salome C.M., and Woolcock A.J. Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease. Am Rev Respir Dis 132 (1985) 25-29
32. Tashkin D.P., Altose M.D., Bleecker E.R., et al. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis 145 (1992) 301-310
33. Burrows B., Lebowitz M.D., and Barbee R.A. Respiratory disorders and allergy skin-test reactions. Ann Intern Med 84 (1976) 134-139
34. Orie N.G.M. The Dutch hypothesis. Chest 117 (2000) 299S
35. Viegi G., Pedreschi M., Pistelli F., et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 117 (2000) 339S-345S
36. Shaheen S.O., Sterne J.A.C., Tucker J.S., et al. Birth weight, childhood lower respiratory tract infection, and adult lung function. Thorax 53 (1998) 549-553
37. Tager A.M., and Luster A.D. BLT1 and BLT2: the leukotriene B4 receptors. Prostagland, Leukotrienes Essential Fatty Acids 69 (2003) 123-134
38. Hogg J.C. Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 160 (1999) S26-S28
39. Cotes J.E., Chinn D.J., Quanjer P.H., et al. Standardization of the measurement of transfer factor (diffusing capacity). Report working party standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 16 Suppl. (1993) 41-52
40. Roberts C.M., MacRae K.D., Winning A.J., et al. Reference values and prediction equations for normal lung function in a non-smoking white urban population. Thorax 46 (1991) 643-650
41. Welle I., Eide G.E., Bakke P., et al. Applicability of the single-breath carbon monoxide diffusing capacity in a Norwegian Community Study. Am J Resp Critl Care Med 158 (1998) 1745-1750
42. Viegi G., Paoletti P., Prediletto R., et al. Carbon monoxide diffusing capacity, other indices of lung function, and respiratory symptoms in a general population sample. Am Rev Respir Dis 141 (1990) 1033-1039
43. Sansores R.H., Abboud R.T., Kennell C., et al. The effect of menstruation on the pulmonary carbon monoxide diffusing capacity. Am J Respir Crit Care Med 152 (1995) 381-384
44. Douma W.R., de Gooijer A., Rijcken B., et al. Lack of correlation between bronchoconstrictor response and bronchodilator response in a population-based study. Eur Respir J 10 (1997) 2772-2777
45. Reid D.W., Soltani A., Johns D.P., et al. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease. Intern Med J 33 (2003) 572-577